SCHEMBL1361059

SCHEMBL1361059

[S]c1ncn[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3744556 0.67 IDO1 (0.50) —
SCHEMBL1548449 0.62 — —
SCHEMBL1822949 0.62 — —
SCHEMBL14416088 0.62 — —
SCHEMBL16433080 0.60 — —
SCHEMBL595649 0.57 — —
SCHEMBL7995627 0.57 — —
SCHEMBL1999085 0.57 — —
SCHEMBL2238449 0.57 — —
SCHEMBL1083825 0.57 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7037931-B2 Corticotropin releasing factor moderator; analgesics; drug abruse, drug dependency; schizophrenia JANSSEN PHARMACEUTICA N.V. (BE) 2006-05-02 — — US claimed
US-20050020565-A1 Pyrazole compound; gastrointestinal disorders; central nervous system disorders JONES TODD K (US) 2005-01-27 — — US claimed
EP-1077957-B1 OXYIMINOALKANOIC ACID DERIVATIVES WITH HYPOGLYCEMIC AND HYPOLIPIDEMIC ACTIVITY TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2004-08-04 — — EP claimed
US-20040067983-A1 CCK-1 receptor modulators JANSSEN PHARMACEUTICA, N.V. (BE) 2004-04-08 — — US claimed
US-8067453-B2 Oxazole compound to treat or prevent diabetic neuropathy; 4-(4-chlorophenyl)-5-(3-(2-methoxyphenoxy)propyl-2-methyl-1-imidazolyl)oxazole TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-11-29 — — US disclosed
US-20100029724-A1 SCREENING METHOD TAKEDA PHARMACEUTICAL COMPANY LIMITED 2010-02-04 — — US disclosed
EP-2039779-A1 SCREENING METHOD Takeda Pharmaceutical Company Limited (JP) 2009-03-25 — — EP disclosed
US-7498352-B2 TGF-β superfamily production/secretion promoter TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-03-03 — — US disclosed
US-7465808-B2 CCK-1 receptor modulators JANSSEN PHARMACEUTICA, N.V. (BE) 2008-12-16 — — US disclosed
US-7462635-B2 Thiazole and oxazole VDAC regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-12-09 — — US disclosed
US-20080287438-A1 Agent for preventing or treating neuropathy MOMOSE YU 2008-11-20 — — US disclosed
US-20080269219-A1 Neurotrophin production/secretion promoting agent TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-10-30 — — US disclosed
US-4959299-A DEVELOPMENT INHIBITOR-RELEASING AND BLEACH ACCELERATING AGENT-RELEASING COUPLERS FUJI PHOTO FILM CO., LTD. (JP) 1990-09-25 — — US disclosed
US-4883879-A CHEMICAL INTERMEDIATES KAKEN PHARMACEUTICAL CO., LTD. (JP) 1989-11-28 — — US disclosed
US-4822786-A Cephalosporin compounds, and antibacterial agents KAKEN PHARMACEUTICAL CO., LTD. (JP) 1989-04-18 — — US disclosed
EP-0305939-A1 Process of producing sulfonylurea derivatives Takeda Chemical Industries, Ltd. (JP) 1989-03-08 — — EP disclosed
EP-0251299-A2 Cephalosporin compounds, processes for their preparation and antibacterial agents Kaken Pharmaceutical Co., Ltd. (JP) 1988-01-07 — — EP disclosed
EP-0238070-A2 Sulfonylurea compounds, their production and herbicidal use Takeda Chemical Industries, Ltd. (JP) 1987-09-23 — — EP disclosed
US-4400517-A PESTICIDES; APHIDICIDES; PARASITICIDES MONTEDISON S.P.A. (IT) 1983-08-23 — — US disclosed
US-4220789-A CYCLIZATION OF A SEMICARBAZONE MONTEDISON S.P.A. (IT) 1980-09-02 — — US disclosed
Send feedback